NEW YORK – Sequencing-based approaches may not replace biochemical- or phenotypic-based newborn screening, but may supplement those approaches, according to a new study.
Newborn screening began in the 1960s to detect conditions like phenylketonuria and has since expanded as there are now some 35 core and 26 secondary conditions that guidelines recommend be included in newborn screening programs.